Condition
Acne Keloidalis Nuchae
Total Trials
6
Recruiting
0
Active
0
Completed
3
Success Rate
60.0%-27% vs avg
Key Insights
Highlights
Success Rate
60% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 55/100
Termination Rate
33.3%
2 terminated out of 6 trials
Success Rate
60.0%
-26.5% vs benchmark
Late-Stage Pipeline
50%
3 trials in Phase 3/4
Results Transparency
67%
2 of 3 completed with results
Key Signals
2 with results60% success
Data Visualizations
Phase Distribution
6Total
Not Applicable (3)
P 3 (1)
P 4 (2)
Trial Status
Completed3
Terminated2
Unknown1
Trial Success Rate
60.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT05608499Phase 3TerminatedPrimary
Duobrii Treatment of Acne Keloidalis Nuchae (AKN)
NCT01328080Not ApplicableCompletedPrimary
Treatment of Acne Keloidalis Nuchae (Razor Bumps Behind the Neck) Using UV Light Therapy
NCT02372786Phase 4Completed
7% Lidocaine/7% Tetracaine Cream Versus 2,5% Lidocaine / 2,5% Prilocaine Cream
NCT00476697Not ApplicableTerminated
UVA1 Light for Scleroderma and Similar Conditions
NCT00757315Not ApplicableUnknownPrimary
NdYag Laser for Acne Keloidalis Nuchae
NCT01548898Phase 4CompletedPrimary
The Efficacy of Laser Assisted Hair Removal in the Treatment of Acne Keloidalis Nuchae; a Pilot Study
Showing all 6 trials